Promising AI Tool for Lung Cancer
Tuesday, September 9, 2025
Mary Pasquinelli, DNP, APRN, FNP-BC, director of the Lung Screening Program at UI Health and a member of the University of Illinois Cancer Center, presented a study on Sybil, a deep learning artificial intelligence model for predicting future lung cancer risk in a predominantly Black population, at the International Association for the Study of Lung Cancer (IASLC) 2025 World Conference on Lung Cancer in Barcelona, Spain.
The University of Illinois Chicago (UIC), which includes UI Health and the Cancer Center, is part of the Sybil Implementation Consortium, which also comprises Mass General Brigham, Baptist Memorial Health Care, Massachusetts Institute of Technology, and WellStar Health System.
Sybil had a strong performance in a real-world clinical setting with racially and socioeconomically diverse patients.
Pasquinelli is the UIC lead for the Sybil Implementation Consortium, an IASLC board director, and a member of the Cancer Center's Cancer Prevention and Control Research Program. The study's senior author is Frank Weinberg, MD, PhD, who practices at UI Health and is a member of the Cancer Center's Translational Oncology Research Program.
